The drugmaker will reduce its workforce by offering employees a financial incentive to voluntarily resign.
Eli Lilly employs about 1,400 people at the plant, which produces insulin and oncology drugs.
More articles on pharmacy:
Hospital-owned drug company attracts 12 more health systems
How nurses are becoming integral to pharma marketing: 7 notes
4 tips for managing drug spend from Alameda Health System’s Dr. Yi-Chih Peng
Next Up in Pharmacy
-
Viatris has completed its acquisition of Pacira BioSciences, a non-opioid pain management company. The transaction closed Nov. 17, after Viatris…
-
The FDA granted accelerated approval to Nuvalent’s Nelkarmi (neladalkib) Nov. 17 for adults with previously treated, locally advanced or metastatic…
-
Author’s note: The concepts described herein are intended as a strategic framework rather than a prescriptive operating model. Health systems…
Join the 500,000+ healthcare executives who start their day with Becker's
Becker's Hospital Review Newsletter is sent Monday–Sunday.